Mqs Management LLC Biogen Inc. Transaction History

Mqs Management LLC

$177 Million
Q3 2024

A detailed history of Mqs Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Mqs Management LLC holds 3,256 shares of BIIB stock, worth $514,122. This represents 0.36% of its overall portfolio holdings.

Number of Shares

3,256

Holding current value

$514,122

% of portfolio

0.36%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 05, 2024	BUY	$189.07 - $236.8 $615,611 - $771,020	3,256 New	3,256 $631,000
Q1 2024 May 13, 2024	BUY	$212.02 - $267.71 $426,160 - $538,097	2,010 New	2,010 $433,000

Others Institutions Holding BIIB

# of Institutions

1,036

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.63 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.58 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.3 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.16 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$810 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mqs Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mqs Management LLC with notifications on news.

Account